Minerva Surgical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-35.55	-34.11	-21.46	-18.26	-69.8
Depreciation & Amortization	8.7	10.81	10.62	7.08	1.68
Share-Based Compensation	5.01	6.98	6.82	0.86	0.59
Other Operating Activities	-16.89	-19.24	-18.35	-1.91	47.74
Operating Cash Flow	-38.73	-35.57	-22.38	-12.24	-19.79
Capital Expenditures	-0.07	-0.07	-0.58	-0.45	-0.22
Acquisitions	0	0	0	-15	0
Other Investing Activities	0.02	-	-25	-	-
Investing Cash Flow	-0.05	-0.07	-25.58	-15.45	-0.22
Common Stock Issued	26.78	0.04	70.73	0.12	0.11
Share Repurchases	26.77	0	0	0	0
Other Financing Activities	26.85	-5	0.49	17.96	43.05
Financing Cash Flow	26.86	-4.96	71.21	18.08	43.16
Net Cash Flow	-11.93	-40.6	23.25	-9.62	23.14
Free Cash Flow	-38.8	-35.64	-22.96	-12.69	-20.02
Free Cash Flow Margin	-75.06%	-70.86%	-44.07%	-33.61%	-76.95%
Free Cash Flow Per Share	-4.37	-24.74	-65.49	-12.45	-21.59

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.